James E. Shields
Direttore/Membro del Consiglio presso Allos Therapeutics, Inc.
Provenienza dei contatti di primo grado di James E. Shields
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 17 | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.
16
| Subsidiary | Pharmaceuticals: Major | 16 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a James E. Shields tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
SEQUUS Pharmaceuticals, Inc.
 SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer Chief Executive Officer Chief Operating Officer | |
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Investment Committee Member Private Equity Investor | |
| ANTARES PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Goldman Sachs Asset Management LP
 Goldman Sachs Asset Management LP Investment ManagersFinance Goldman Sachs Asset Management LP (GSAMLP) is a SEC-registered investment advisor headquartered in New York City. The firm is a wholly owned subsidiary of GSAM Holdings LLC, and their ultimate parent is Goldman Sachs Group, Inc. (NYSE: GS). Founded in 1988, GSAMLP provides investment solutions to a range of individual and institutional investors worldwide. | Investment Managers | Corporate Officer/Principal | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst | |
| TRAWS PHARMA, INC. | Biotechnology | President Corporate Officer/Principal | |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Edgemont Pharmaceuticals LLC
 Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Edgemont Pharmaceuticals LLC develops and provides products for psychiatric disorders. The company was founded by Douglas A. Saltel in 2008 and is headquartered in Austin, TX. | Pharmaceuticals: Major | Director/Board Member | |
| Stanford University | College/University | Doctorate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree | |
Irvine Biomedical, Inc.
 Irvine Biomedical, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Abbott Laboratories, Irvine Biomedical, Inc. develops electrophysiology catheter products. The company is based in Irvine, CA. Irvine Biomedical was acquired by St. Jude Medical LLC, part of Abbott Laboratories from January 05, 2017 on October 07, 2004 for $47 million. | Electronic Equipment/Instruments | Director of Finance/CFO | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Warburg Pincus & Company US LLC
 Warburg Pincus & Company US LLC Investment ManagersFinance Warburg Pincus & Company US LLC engages in the provision of investment services. The company is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Colorado | College/University | Graduate Degree Masters Business Admin | |
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas. | Investment Managers | Private Equity Investor | |
Cardiac Science Corp.
 Cardiac Science Corp. Medical SpecialtiesHealth Technology Cardiac Science Corp. develops, manufactures, and markets Powerheart automated external defibrillators. Its offers power heart AED G5, G5 trainer, G3 plus, G3 Pro, G3 trainer, and rescue ready services. The company was founded in 1913 and is headquartered in Waukesha, WI. | Medical Specialties | Director of Finance/CFO | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
Oikos Holdings LLC
 Oikos Holdings LLC Investment ManagersFinance Oikos Holdings LLC is a financial advisory services holding private company. The company is based in New York, NY and has subsidiaries in the United States. The company was founded by Kevin Thomas Ferro. | Investment Managers | Chief Executive Officer | |
| Pain Concepts, Inc. | Director of Finance/CFO | ||
| Lucile Packard Foundation for Children’s Health | Investment Trusts/Mutual Funds | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
LaVie Care Centers LLC
 LaVie Care Centers LLC Medical/Nursing ServicesHealth Services Part of Consulate Management Co., LLC, LaVie Care Centers LLC is a company that offers a range of services including comprehensive short-term rehabilitation, transitional care, Alzheimer's and dementia care, long-term care, and assisted and independent living. The company is based in Maitland, FL. The company focuses on creating rigorous systems of care and deploying technology to better understand patient needs. | Medical/Nursing Services | Director/Board Member | |
| Harvard Business School Health Industry Alumni Association | Director/Board Member | ||
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member | |
| Citizens Oncology Foundation | Director/Board Member | ||
Oberland Capital Management LLC
 Oberland Capital Management LLC Investment ManagersFinance Oberland Capital Management LLC (Oberland Capital) is a private equity firm founded in 2013 by Jean-Pierre Naegeli and Andrew Rubinstein. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree | |
| Solana Therapeutics, Inc. | Chief Executive Officer | ||
| ODONATE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MELINTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
RBNC Therapeutics, Inc.
 RBNC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology RBNC Therapeutics, Inc. develops and commercializes therapies for individuals with brain diseases. | Pharmaceuticals: Major | Chairman | |
| REVELATION BIOSCIENCES, INC. | Biotechnology | Chairman Director/Board Member | |
Revelation Biosciences Sub, Inc.
 Revelation Biosciences Sub, Inc. Medical SpecialtiesHealth Technology Part of Revelation Biosciences, Inc., Revelation Biosciences Sub, Inc. develops medical devices. The company is based in San Diego, CA. James M. Rolke has been the CEO of the company since 2020. Revelation Biosciences Sub was acquired by Petra Acquisition, Inc. on January 11, 2022 for $87.36 million. | Medical Specialties | Chairman Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 49 |
| Paesi Bassi | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 26 |
| Consumer Services | 10 |
| Finance | 8 |
| Electronic Technology | 2 |
| Distribution Services | 2 |
Posizioni
| Director/Board Member | 128 |
| Corporate Officer/Principal | 78 |
| Independent Dir/Board Member | 42 |
| Undergraduate Degree | 27 |
| President | 24 |
Contatti più connessi
| Insiders | |
|---|---|
| Jonathan Leff | 45 |
| Paul Berns | 28 |
| George Tidmarsh | 22 |
| Cecilia Gonzalo | 20 |
| David Stout | 19 |
| Rajesh Shrotriya | 16 |
| Anton G. Gueth | 16 |
| Gilles Gagnon | 15 |
| Brett Scott | 14 |
| Steven Fruchtman | 11 |
| Abraham Noah Oler | 11 |
| Charles Q. Morris | 10 |
| Bruce Goldsmith | 10 |
| Luigi Lenaz | 10 |
| Dilip J. Mehta | 9 |
- Borsa valori
- Insiders
- James E. Shields
- Connessioni Società
